Europe approves Allied Healthcare's regenerative product

08/26/2013 | BioSpectrum Asia

Allied Healthcare has earned the CE mark to market CardioCel, the company's lead regenerative product, in Europe. The device is used for the repair of cardiac defects, including those related to heart valves and congenital heart disease in adults and children.

View Full Article in:

BioSpectrum Asia

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC